National Quality Indicators in Pediatric Sickle Cell Anemia.

ABSTRACT:

Objective

To assess nationally endorsed claims-based quality measures in pediatric sickle cell anemia (SCA).

Methods

Using data from the Sickle Cell Data Collection programs in California and Georgia from 2010 to 2019, we evaluated 2 quality measures in individuals with hemoglobin S/S or S/β-zero thalassemia: (1) the proportion of patients aged 3 months to 5 years who were dispensed antibiotic prophylaxis for at least 300 days within each measurement year and (2) the proportion of patients aged 2 to 15 years who received at least 1 transcranial Doppler ultrasound (TCD) within each measurement year. We then evaluated differences by year and tested whether performance on quality measures differed according to demographic and clinical factors.

Results

Only 22.2% of those

SUBMITTER: Anderson AT 

PROVIDER: S-EPMC10982541 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature